A randomised, controlled, double blind, escalating dose study of alicaforsen enema in active ulcerative colitis

Gut

Volumn 53, Issue 11, 2004, Pages 1646-1651

  Van Deventer, S J H ^a   Tami, J A ^b   Wedel, M K ^b  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ISIS PHARMACEUTICALS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALICAFORSEN; CELL ADHESION MOLECULE; ENEMA; PLACEBO;

ADULT; ARTICLE; ASTHENIA; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ACTIVITY; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; HUMAN TISSUE; INFECTION; MALE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SIDE EFFECT; TREATMENT INDICATION; TREATMENT OUTCOME; ULCERATIVE COLITIS;

ADULT; COLITIS, ULCERATIVE; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; ENEMA; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; MALE; MIDDLE AGED; OLIGODEOXYRIBONUCLEOTIDES, ANTISENSE; SEVERITY OF ILLNESS INDEX; THIONUCLEOTIDES; TREATMENT OUTCOME;

EID: 7244252832     PISSN: 00175749     EISSN: None     Source Type: Journal    
DOI: 10.1136/gut.2003.036160     Document Type: Article

References (22)

1. Cohen RD, Woseth DM, Thisted RA, et al. A meta-analysis and overview of the literature on treatment options for left-sided colitis. Am J Gastroenterol 2000;95:1263-76.
2. Marshall JK, Irvine EJ. Putting rectal 5-aminosalicylic acid in its place: the role in distal ulcerative colitis. Am J Gastroenterol 2000;95:1628-36.
3. Dustin ML, Rothlein R, Bhan AK, et al. Induction by IL-1 and Interferon: tissue distribution, biochemistry, and function of a natural adherence molecule (ICAM-1). J Immunol 1986;137:245-54.
4. Rothlein R, Dustin ML, Marlin SD, et al. A human intercellular adhesion molecule (ICAM-1) distinct from LFA-1. J Immunol 1986;137:1270-4.
5. Simmons D, Makgoba MW, Seed B. ICAM, an adhesion ligand of LFA-1, is homologous to the neural cell adhesion molecule NCAM. Nature 1988;331:624-7.
6. Marlin SD, Springer TA. Purified intercellular adhesion molecule-1 (ICAM-1) is a ligand for lymphocyte function-associated antigen-1 (LFA-1). Cell 1987;51:813-19.
7. Diamond MS, Staunton DE, deFougerolles AR, et al. ICAM-1 (CD54): a counter-receptor for Mac-1 (CD11b/CD18). J Cell Biol 1990;111:3129-39.
8. Butcher EC. Leukocyte-endothelial cell recognition: Three (or more) steps to specificity and diversity. Cell 1991;67:1033-6.
9. Furie MB, Tancinco MCA, Smith CW. Monoclonal antibodies to leukocyte chemoattractant-stimulated neutrophil transendothelial migration in vitro. Blood 1991;78:2089-97.
10. Oppenheimer-Marks N, Davis LS, Bogue DT, et al. Differential utilization of ICAM-1 and VCAM-1 during the adhesion and transendothelial migration of human T lymphocytes. J Immunol 1991;147:2913-21.
11. Van Aasche G, Rutgeerts P. Antiadhesion molecule therapy in inflammatory bowel disease. Inflamm Bowel Dis 2002;8:291-300.
12. Bennett CF, Kornbrust D, Henry S, et al. An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice. Gastroenterology 1998;114:1133-42.
13. Taniguchi T, Tsukada H, Nakamura H, et al. Effects of the anti-ICAM-1 monoclonal antibody on dextran sodium sulphate sodium-induced colitis in rats. J Gastroenterol Hepatol 1998;13:945-9.
14. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. N Engl J Med 1987;317:1625-9.
15. Truelove SC, Wilts U. Cortisone in ulcerative colitis. BMJ 1955;2:1041-8.
16. Yu RZ, Baker B, Chappell A, et al. Development of an ultrasensitive noncompetitive hybridization-ligation enzyme-linked immunosorbent assay for the determination of phosphorothioate oligodeoxynucleotide in plasma. Anal Biochem 2002;304:19-25.
17. Vainer B, Nielsen OH. Changed colonic profile of P-selectin, platelet-endothelial cell adhesion molecule-1 (PECAM-1), intercellular adhesion molecule-1 (ICAM-1), ICAM-2, and ICAM-3 in inflammatory bowel disease. Clin Exp Immunol 2000;121:242-7.
18. Vainer B, Sorenson S, Nielsen OH, et al. Subcellular localization of intercellular adhesion molecule-1 in colonic mucosa in ulcerative colitis. Ultrastruct Pathol 2002;26:113-21.
19. Wu H, Lima WF, Crooke ST. Properties of cloned and expressed human RNase H1. J Biol Chem 1999;274:2870-8.
20. Bennett CF, Condon T, Grimm S, et al. Inhibition of endothelial cell-leukocyte adhesion molecule expression with antisense oligonucleotides. J Immunol 1994;152:3530-40.
21. Bennett CF, Kornbrust D, Henry S, et al. An ICAM-1 antisense oligonucleotide prevents and reverses dextran sulfate sodium-induced colitis in mice. J Pharmacol Exp Ther 1997;280:988-1000.
22. Yacyshyn BR, Chey WY, Goff J, et al. Double blind, placebo controlled trial of the remission inducing and steroid sparing properties of an ICAM-1 antisense oligodeoxynucleotide, alicaforsen (ISIS 2302), in active steroid dependent Crohn's disease. Gut 2002;51:30-6.